Jaguar Health, Inc.
JAGX
$1.76
-$0.03-1.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 34.55% | -36.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 34.55% | -36.91% | |||
| Cost of Revenue | 2.33% | -7.54% | |||
| Gross Profit | 44.32% | -42.45% | |||
| SG&A Expenses | -2.65% | 12.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.58% | -0.27% | |||
| Operating Income | 15.01% | -15.50% | |||
| Income Before Tax | 0.34% | -3.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.34% | -3.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 15.91% | -57.96% | |||
| Net Income | 0.54% | -5.48% | |||
| EBIT | 15.01% | -15.50% | |||
| EBITDA | 15.80% | -16.45% | |||
| EPS Basic | 38.58% | 19.83% | |||
| Normalized Basic EPS | 49.50% | 18.89% | |||
| EPS Diluted | 38.58% | 19.83% | |||
| Normalized Diluted EPS | 49.50% | 18.89% | |||
| Average Basic Shares Outstanding | 61.95% | 31.56% | |||
| Average Diluted Shares Outstanding | 61.95% | 31.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||